| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 104.68B | 105.41B | 102.56B | 101.89B | 99.46B | 110.67B |
| Gross Profit | 26.18B | 29.35B | 25.38B | 24.99B | 24.81B | 28.89B |
| EBITDA | 3.97B | 4.53B | 2.76B | 3.96B | 3.57B | 3.89B |
| Net Income | -806.00M | 1.24B | -2.62B | 451.00M | 205.00M | 368.00M |
Balance Sheet | ||||||
| Total Assets | 56.11B | 51.99B | 55.58B | 58.19B | 54.26B | 49.62B |
| Cash, Cash Equivalents and Short-Term Investments | 6.29B | 5.37B | 5.75B | 6.03B | 5.35B | 6.15B |
| Total Debt | 11.38B | 9.59B | 15.31B | 15.58B | 10.42B | 5.29B |
| Total Liabilities | 29.48B | 25.38B | 29.61B | 29.32B | 25.62B | 20.81B |
| Stockholders Equity | 26.62B | 26.60B | 25.97B | 28.86B | 28.64B | 28.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.42B | 1.71B | -1.86B | -4.24B | -603.00M |
| Operating Cash Flow | 0.00 | 5.95B | 3.32B | 1.63B | 1.93B | 2.25B |
| Investing Cash Flow | 0.00 | 1.06B | -2.40B | -3.54B | -7.13B | -3.11B |
| Financing Cash Flow | 0.00 | -7.39B | -1.20B | 2.60B | 4.40B | -699.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥109.31B | 11.71 | ― | 1.92% | 2.00% | 9.16% | |
71 Outperform | ¥84.31B | 10.02 | ― | 1.47% | 7.10% | 0.95% | |
69 Neutral | ¥145.65B | 13.26 | ― | 1.64% | 9.19% | 2.45% | |
66 Neutral | ¥31.25B | 14.62 | ― | 2.22% | 12.15% | -0.86% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥12.69B | 10.26 | ― | 2.32% | 2.78% | ― | |
62 Neutral | ¥60.07B | 11.40 | ― | 1.34% | 22.67% | 17.06% |